Medicare Enrolled
Dr. Anthony O'Meara, M.D.
Family Medicine · Mcdonough, GA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. O'Meara from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. O'Meara?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. O'Meara
Dr. Anthony O'Meara is a family medicine specialist in Mcdonough, GA, with 18 years of NPI registration. Based on federal Medicare data, Dr. O'Meara performed 2,054 Medicare services across 1,345 unique beneficiaries.
Between the years covered by Open Payments, Dr. O'Meara received a total of $7,756 from 54 pharmaceutical and/or device companies across 459 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. O'Meara is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 17% volume in GA
$7,756 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,054
Medicare services
Top 17% in GA for family medicine
1,345
Unique beneficiaries
$58
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~114 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
582 | $90 | $292 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
249 | $2 | $5 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
211 | $0 | $30 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
196 | $127 | $298 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
155 | $65 | $206 |
| Hemoglobin A1c test (diabetes monitoring) A blood test that measures your average blood sugar levels over the past two to three months. |
117 | $10 | $25 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
80 | $10 | $32 |
| Ceftriaxone antibiotic injection This code represents the administration of ceftriaxone sodium, an antibiotic medication. The charge is calculated for every 250 mg of the drug administered. |
59 | $0 | $7 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
56 | $31 | $50 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
52 | $72 | $122 |
| Annual wellness visit, initial visit A yearly appointment to review your health and create a personalized prevention plan. This initial visit focuses on preventive care and health assessment. |
40 | $163 | $376 |
| Respiratory virus detection test A laboratory test using immunoassay techniques to detect the presence of severe acute respiratory syndrome coronavirus and influenza viruses. |
39 | $45 | $131 |
| Health risk assessment administration and interpretation This procedure involves administering a health risk assessment to a patient and interpreting the results. |
35 | $2 | $7 |
| Transitional care management services, moderate complexity Services provided to coordinate care during the transition from an inpatient or other facility setting back to the community. This includes follow-up and management of a health problem of at least moderate complexity. |
32 | $159 | $467 |
| Pneumococcal conjugate vaccine (PCV20) An intramuscular injection of the 20-valent pneumococcal conjugate vaccine. It is used to protect against diseases caused by Streptococcus pneumoniae bacteria. |
24 | $269 | $450 |
| Pneumonia vaccine administration This procedure involves the injection of a vaccine to protect against pneumococcal disease. It is administered by a healthcare provider. |
24 | $31 | $50 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
20 | $121 | $376 |
| Assessment of emotional or behavioral problems An evaluation to identify and understand emotional or behavioral issues. This process involves reviewing symptoms and behaviors to determine the nature of the concerns. |
19 | $3 | $12 |
| Hemoglobin a1c level, by device for home use | 18 | $10 | $19 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
18 | $40 | $128 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
17 | $11 | $34 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
11 | $64 | $254 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$7,756
Total received (2018-2024)
Avg $1,108/year across 7 years
Top 8% in GA for family medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
54
Companies
459
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,672 (98.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$84 (1.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,884
2023
$1,996
2022
$1,343
2021
$1,449
2020
$661
2019
$299
2018
$124
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novo Nordisk Inc
$271
AstraZeneca Pharmaceuticals LP
$264
Lilly USA, LLC
$234
PFIZER INC.
$179
GlaxoSmithKline, LLC.
$144
Otsuka America Pharmaceutical, Inc.
$129
SHIELD THERAPEUTICS INC
$117
Astellas Pharma US Inc
$84
Boehringer Ingelheim Pharmaceuticals, Inc.
$66
Amgen Inc.
$63
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$61
Corium, LLC
$55
IDORSIA PHARMACEUTICALS US INC
$36
ABBVIE INC.
$26
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$26
Bausch Health US, LLC
$23
Novartis Pharmaceuticals Corporation
$21
Bayer Healthcare Pharmaceuticals Inc.
$20
Paratek Pharmaceuticals, Inc.
$20
Merck Sharp & Dohme LLC
$15
Exact Sciences Corporation
$15
Antares Pharma, Inc.
$14
Top 3 companies account for 40.8% of 2024 payments
All-time payments by company (2018-2024) ›
Lilly USA, LLC
$806
Novo Nordisk Inc
$771
AstraZeneca Pharmaceuticals LP
$604
ABBVIE INC.
$555
Amgen Inc.
$465
PFIZER INC.
$401
Corium, LLC
$301
GlaxoSmithKline, LLC.
$288
Boehringer Ingelheim Pharmaceuticals, Inc.
$272
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$260
AbbVie Inc.
$227
Amarin Pharma Inc.
$226
Astellas Pharma US Inc
$208
Biohaven Pharmaceutical Holding Company Ltd.
$176
Otsuka America Pharmaceutical, Inc.
$176
Novartis Pharmaceuticals Corporation
$171
Biohaven Pharmaceuticals, Inc.
$150
Grifols USA, LLC
$133
Merck Sharp & Dohme LLC
$123
SHIELD THERAPEUTICS INC
$117
Eisai Inc.
$110
Teva Pharmaceuticals USA, Inc.
$97
Bayer HealthCare Pharmaceuticals Inc.
$78
IDORSIA PHARMACEUTICALS US INC
$72
Allergan, Inc.
$66
Phadia US Inc.
$65
Medline Industries, Inc.
$65
Shield Therapeutics Inc
$64
Bayer Healthcare Pharmaceuticals Inc.
$64
Takeda Pharmaceuticals U.S.A., Inc.
$62
Merck Sharp & Dohme Corporation
$61
Allergan Inc.
$52
JAZZ PHARMACEUTICALS INC.
$44
Supernus Pharmaceuticals, Inc.
$42
Dexcom, Inc.
$32
Exact Sciences Corporation
$30
Mylan Specialty L.P.
$29
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$26
Almatica Pharma LLC
$24
Bausch Health US, LLC
$23
Sunovion Pharmaceuticals Inc.
$22
Paratek Pharmaceuticals, Inc.
$20
SANOFI-AVENTIS U.S. LLC
$18
UPSHER-SMITH LABORATORIES LLC
$18
DERMIRA, INC.
$17
Janssen Pharmaceuticals, Inc
$16
Bardy Diagnostics, Inc.
$15
Mylan Pharmaceuticals Inc.
$15
Lundbeck LLC
$15
Antares Pharma, Inc.
$14
Tolmar, Inc.
$14
Adlon Therapeutics L.P.
$12
Acerus Pharmaceuticals Corporation
$12
Melinta Therapeutics, Inc.
$12
Top 3 companies account for 28.1% of all-time payments
Associated products mentioned in payments ›
ACCRUFER · ADHANSIA XR · AIMOVIG · AIRSUPRA · AJOVY · APLENZIN · AREXVY · Aimovig · Azstarys · BASAGLAR · BELSOMRA · BEXSERO · BREZTRI · BREZTRI AEROSPHERE · BYDUREON · BYSTOLIC · Baxdela · CAPLYTA · COLOGUARD DNA CAPTURE REAGENTS · COMIRNATY · Carnation Ambulatory Monitor · Cologuard Collection Kit · Dayvigo · Dexcom G6 Transmitter · ELIQUIS · EMGALITY · ENTRESTO · EVENITY · FARXIGA · GARDASIL · GRALISE · ImmunoCAP · JANUVIA · JARDIANCE · JATENZO · Kerendia · LATUDA · LEQVIO · LINZESS · MOUNJARO · MYRBETRIQ · NURTEC ODT · NUZYRA · Natesto · Otezla · Ozempic · PAXLOVID · PNEUMOVAX 23 · Prolastin-C · Prolastin-C Liquid · QELBREE · QULIPTA · QUVIVIQ · REXULTI · Rybelsus · SHINGRIX · SOLIQUA 100/33 · STEGLATRO · SUNOSI · SYNTHROID · Saxenda · TOSYMRA · TRELEGY ELLIPTA · TRINTELLIX · TRULICITY · TRUMENBA · UBRELVY · VIBERZI · VRAYLAR · VYVANSE · Vascepa · Veozah · Wegovy · XARELTO · XIFAXAN · XYOSTED · Xulane · Yupelri · ZEPBOUND
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 8% for family medicine in GA.
Geographic Context
Family medicine physicians within 10 mi
511
Per 100K population
208.2
County median income
$81,612
Nearest hospital
PIEDMONT HENRY HOSPITAL
7.2 mi
7.2 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. O'Meara is a clinical cardiology specialist, with above-average Medicare volume (top 17% in GA), with low-engagement industry engagement in the top 8% of GA peers, with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. O'Meara experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. O'Meara performed 582 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. O'Meara receive payments from pharmaceutical companies?
Yes. Dr. O'Meara received a total of $7,756 from 54 companies across 459 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. O'Meara's costs compare to other family medicine physicians in Mcdonough?
Dr. O'Meara's average Medicare payment per service is $58. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. O'Meara) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Family Medicine
Common procedures, typical costs, and what industry payments mean in family medicine.
Same specialty & city
Family Medicine Physicians in Mcdonough
Browse family medicine physicians in Mcdonough ranked by procedure volume and transparency data.
Highest volume
Top Family Medicine Physicians in GA
Family medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Medicine Physicians in GA
Which GA family medicine physicians receive the most from drug and device companies.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology